n CME : Your SA Journal of CPD - Cervical cancer screening - a new viral paradigm : main article

Volume 29, Issue 5
  • ISSN : 0256-2170



There is now enough scientific evidence available to predict that conventional cervical cancer screening with cytology will eventually be replaced by testing for markers of HPV infection associated with disease progression. It is vital that clinicians understand the benefits, limitations and harms of testing. False-positives can be reduced by adhering to the guidelines for age-related testing and the recommended longer screening intervals. Patients must be well informed regarding the role of HPV infection testing in cervical cancer screening.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error